MIM
MPTI.RT

MetLife Investment Management’s M-tron Industries Rights (expiring April 15 2026) MPTI.RT Stock Holding History

MetLife Investment Management’s Portfolio MPTI.RT Stock Details MPTI.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.34K Buy
+1,591
New +$3.34K ﹤0.01% 2761

Other funds holding MPTI.RT

EI
EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return
GI
GAMCO Investors Greenwich, Connecticut $10.2B AUM 30.27% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
HIM
Herald Investment Management London, United Kingdom $737M AUM 158.15% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

MetLife Investment Management's MPTI.RT Position: Q1 2026 in Review

MetLife Investment Management opened a new position in M-tron Industries Rights (expiring April 15 2026) (MPTI.RT) in Q1 2026: 1,591 shares worth $3.34K. The stake represents ﹤0.01% of the portfolio and ranks #2761 among its holdings.

43 funds tracked by Wall St. Rank hold MPTI.RT as of Q1 2026.

  • MetLife Investment Management held 1,591 shares of M-tron Industries Rights (expiring April 15 2026) worth $3.34K as of Q1 2026.
  • M-tron Industries Rights (expiring April 15 2026) was a new MetLife Investment Management position in Q1 2026.
  • M-tron Industries Rights (expiring April 15 2026) made up ﹤0.01% of MetLife Investment Management's portfolio in Q1 2026, its #2761 holding.
  • 43 funds tracked by Wall St. Rank held M-tron Industries Rights (expiring April 15 2026) as of Q1 2026.

Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.